The International Pharmaceutical Excipients Federation is laying out a welcome mat for gelatin makers to operate in India because a shortage is causing drugmakers problems.
Sanofi CEO Chris Viehbacher said that investigators would push ahead with the first human studies of the therapy next year.
If passed, approval and reimbursement issues will likely become obstacles.
The Swedish CDMO says it will use the money to fund its growth.
The company has created a joint venture with Manipal Group in India to tap that market primarily for sales of its mobile monitoring devices.
Healthsense, a Minnesota maker of wireless "passive" medical devices designed to monitor the elderly in their homes, is in the middle of raising $13.7 million, a regulatory filing reveals.
A new PricewaterhouseCoopers report suggests that companies aren't innovating fast enough to keep up with the country's rapid evolution into a broader and more sophisticated market.
Cardiovascular Systems ($CSII) wants to raise $15 million in a public offering, the Minnesota-based device company said, as it increases spending for a pivotal clinical trial.
A partnership between Quality Chemical Industries and Cipla is preparing to expand a manufacturing operation in Luzira, Uganda, where it makes HIV drugs.
If not for the continued sluggish performance of Medtronic's ($MDT) spine division and flat ICD and pacer sales, the company fiscal 2012 fourth quarter earnings growth ended up being pretty solid, if unspectacular.